Fourteen thousand people nationwide may be at risk of developing a potentially deadly fungal infection from steroids linked to a Framingham compounding pharmacy, health officials said Thursday, as they widened the pool of patients to include those who received joint injections from the now-recalled medications. So far, 170 patients who received injections of the painkiller made by New England Compounding Center have been sickened — all but one from a rare form of fungal meningitis — and 14 have died.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help